How to Choose an Optometry Practice Broker for

Optometry practice broker selection determines whether your multi-location portfolio captures full market value or leaves significant proceeds on the table. For a PE-backed portfolio managing 15 locations with $30M in combined revenue, the difference between adequate and excellent representation can exceed $3.6M in a single transaction. This guide provides the enterprise framework for evaluating optometry practice brokers, specifically designed for COOs, VPs of Operations, and acquisition teams managing 3+ location portfolios.

What You’ll Learn

1. Why Does Broker Selection Matter for Multi-Location Groups?
2. What Distinguishes Enterprise-Grade Brokers from Generalists?
3. How Should You Evaluate Broker Fee Structures at Scale?
4. How Should You Assess a Broker’s Due Diligence Capabilities?
5. How Do Top Groups Vet Broker Healthcare Specialization?
6. What Questions Should Your RFP Include?
7. How Do You Align Broker Selection with Portfolio Strategy?
8. Related Reading
9. Sources

Why Does Broker Selection Matter for Multi-Location Groups?

The difference between a generalist business broker and a specialized optometry practice broker becomes magnified when operating at scale. A single-location owner selling their practice faces different challenges than a regional group divesting three underperforming locations or a PE-backed platform acquiring eight practices to consolidate a market.

The Enterprise Complexity Factor

Multi-location transactions introduce variables that single-practice deals never encounter. You’re not just selling a practice; you’re selling operational systems, transferable SOPs, centralized reporting infrastructure, and proven scalability. According to Kaufman Hall’s 2024 M&A analysis, healthcare M&A deal volume increased 9.4% in Q4 2024 to 869 deals, with healthcare services representing the most active subsector at 427 transactions. This volume creates competitive pressure that rewards groups with specialized representation.

Valuation Multiples Depend on Representation Quality

Optometry practices transact at EBITDA multiples ranging from 2.97x to 4.06x for small to medium clinics, according to Peak Business Valuation research. That range represents a 36% variance between low and high outcomes. For a portfolio generating $5M in normalized EBITDA across 10 locations, the difference between a 2.97x and 4.06x multiple represents more than $5.4M in transaction value. Broker selection directly impacts whether your transaction returns $14.8M or $20.3M.

The Multi-Location Premium Requires Specialized Positioning

Brokers who understand enterprise optometry know how to position operational maturity as a valuation driver. Documented SOPs, centralized scheduling systems, standardized EHR implementations, and consistent patient experience protocols command premium multiples. A generalist broker sees these as background details. An enterprise-grade optometry broker positions them as transferable infrastructure that reduces buyer integration risk.

What Distinguishes Enterprise-Grade Brokers from Generalists?

Not all brokers who claim healthcare experience can execute multi-location transactions effectively. The distinction matters most in three operational dimensions that directly affect your transaction outcomes.

Buyer Network Depth and Quality

Enterprise brokers maintain active relationships with PE firms, strategic consolidators, and well-capitalized independents specifically seeking multi-location optometry acquisitions. Generalist brokers typically post listings on marketplaces and wait for inbound interest. The difference in buyer quality affects both valuation and deal certainty.

A broker with established PE relationships can run a targeted process, creating competitive tension among qualified buyers. Industry experience suggests this approach produces materially higher valuations than passive marketplace listings because buyers compete knowing other qualified parties are engaged. For your 5-location group with $8M in combined revenue, competitive bidding dynamics can represent $1M or more in additional transaction value.

Healthcare Regulatory Expertise

Optometry transactions involve Stark Law compliance considerations, state-specific corporate practice of medicine restrictions, and managed care contract assignment complexities. Generalist brokers frequently underestimate these regulatory requirements, leading to deal delays or failed closings.

Enterprise optometry brokers maintain relationships with healthcare transaction attorneys and understand how to structure deals that satisfy regulatory requirements while maximizing value. They know which states permit direct practice ownership, which require management services organization structures, and how to work through corporate practice restrictions that vary by jurisdiction.

Integration Planning Capabilities

PE buyers and strategic acquirers evaluate practices based on integration complexity. A broker who can present your practice with detailed integration timelines, technology migration plans, and staff transition frameworks reduces perceived buyer risk. Lower perceived risk translates to higher valuations and faster closings.

The best enterprise brokers proactively prepare integration documentation before going to market. This can make scope, risk, and diligence needs easier for buyers and advisers to evaluate. SBA sale guidance likewise treats valuation, professional support, agreement terms, and broker fees as explicit parts of a business sale (SBA).

How Should You Evaluate Broker Fee Structures at Scale?

Healthcare practice brokers typically charge 6-12% of sale price, with success-based compensation models dominating the industry according to Practice Transitions Group. Fee structure evaluation for multi-location transactions requires more nuanced analysis than simply comparing percentages.

Understanding Tiered Fee Arrangements

Most enterprise brokers reduce their percentage rate as transaction value rises. A widely cited reference point is the Double Lehman formula, which charges 10-12% on the first million of value, then 8% on the second million, 6% on the third, 4% on the fourth, and 2% beyond that, according to Morgan & Westfield. Some brokers apply that kind of marginal sliding scale, while others quote a single flat rate per transaction-size tier. The illustrative example below shows the flat-rate-per-tier approach, where one percentage applies to the entire deal based on its tier:

For a multi-location group selling a $20M portfolio, a tiered structure results in significantly lower effective commission rates than flat percentage arrangements. Clarify with each broker whether they use flat tier-based or marginal sliding scale calculations, as this affects total fees substantially.

Retainer vs. Success-Only Models

Some brokers require upfront retainers ranging from $25,000 to $100,000 for multi-location engagements. This retainer covers pre-market preparation work including valuation analysis, confidential information memorandum creation, and buyer list development.

Success-only models eliminate upfront costs but may attract brokers less committed to your specific transaction. When evaluating these models, consider whether the broker has sufficient financial resources to invest adequately in your deal without upfront compensation.

Hidden Cost Considerations

Evaluate what the base fee includes versus what generates additional charges. Common add-on costs include:

• Third-party valuation reports ($5,000-$15,000 per location)
• Legal coordination fees (1-2% of transaction value)
• Data room setup and management ($2,000-$5,000)
• Travel expenses for buyer meetings ($10,000-$30,000 for multi-location portfolios)

Request a full fee schedule during the RFP process and confirm that quoted percentages represent all-in costs. A broker quoting 7% with extensive add-ons may cost more than a broker quoting 9% with inclusive pricing.

How Should You Assess a Broker’s Due Diligence Capabilities?

Enterprise optometry acquisitions require structured due diligence that extends beyond single-practice financial reviews. The broker you select should demonstrate mastery of the operational, financial, and strategic dimensions that sophisticated buyers scrutinize.

Evaluating Financial Analysis Depth

Ask potential brokers how they approach multi-location due diligence. Strong brokers analyze each practice independently while also assessing portfolio-level synergies. They should articulate how they handle normalized EBITDA calculations that account for multi-location overhead allocation, same-store revenue trends across 3-5 year periods, and payer mix concentration analysis by location.

According to ODs on Finance methodology, optometry valuations blend income-based approaches using EBITDA multiples, market-based methods using comparable sales data, and asset-based calculations for tangible equipment value. Enterprise brokers should demonstrate fluency with all three methodologies and present location-by-location breakdowns.

Understanding Operational Risk Assessment

Buyers increasingly focus on operational transferability. Evaluate whether the broker understands these dynamics:

Testing Integration Documentation Expertise

Sophisticated buyers want to understand integration complexity before submitting offers. Ask broker candidates to describe what integration documentation they prepare and how it affects buyer offers.

Strong brokers prepare documentation addressing EHR migration timelines by location, staff retention incentive structures, patient communication transition plans, and brand continuity strategies. This preparation reduces buyer due diligence timelines and increases offer competitiveness. Brokers who cannot articulate specific integration deliverables may lack the experience required for multi-location transactions.

How Do Top Groups Vet Broker Healthcare Specialization?

Claimed specialization differs from demonstrated expertise. Use these verification methods to assess whether a broker truly understands enterprise optometry transactions.

Transaction History Analysis

Request a detailed list of completed optometry transactions from the past 36 months, including transaction sizes, time-to-close metrics, and final valuation multiples achieved. Enterprise brokers should demonstrate experience with transactions in your size range and complexity level.

Specifically ask for references from multi-location deals. A broker who has completed dozens of single-practice transactions but only one or two multi-location portfolios may lack the experience needed for your transaction.

Buyer Relationship Verification

Ask the broker to describe their relationships with the top 10 PE firms active in optometry M&A and the top 5 strategic consolidators in your region. Probe for specifics: When did they last complete a transaction with each buyer? What types of practices do those buyers prioritize? What valuation ranges are those buyers currently deploying?

Generalist brokers will provide vague answers about “strong relationships with multiple buyers.” Enterprise specialists will name specific deal contacts, describe recent transactions, and explain buyer-specific preferences and concerns.

Regulatory Knowledge Assessment

Test the broker’s healthcare regulatory knowledge with scenario-based questions. For example: “How would you structure a sale to a PE buyer in a state with corporate practice of medicine restrictions?” Or: “What managed care contract assignment issues should we anticipate for our practices with significant Medicare Advantage enrollment?”

Brokers who hesitate or provide generic answers may lack the specialized knowledge required for your transaction. Healthcare-focused brokers should answer confidently and reference specific deal experiences where they addressed similar issues.

Technology Platform Capabilities

Modern enterprise brokers operate sophisticated deal management platforms that track buyer engagement, manage confidential information access, and provide real-time transaction analytics. Ask for a demonstration of their deal platform and evaluate whether it provides the visibility and control appropriate for a multi-location transaction.

Manual processes using email and spreadsheets may work for single-practice deals but create unacceptable risk for portfolio transactions involving multiple buyer conversations and complex documentation requirements.

What Questions Should Your RFP Include?

Structuring your broker selection as a formal RFP process creates competitive tension and ensures consistent evaluation criteria. The following categories should anchor your RFP requirements.

Qualification Questions

Start with threshold requirements that candidates must satisfy to receive full evaluation:

1. How many optometry-specific transactions have you completed in the past 24 months?
2. What percentage of your practice involves healthcare M&A versus general business brokerage?
3. Describe your firm’s compliance infrastructure for managing confidential healthcare transaction data.
4. What errors and omissions insurance coverage do you maintain specific to healthcare M&A advisory?

Process and Timeline Questions

Understand the broker’s proposed approach and realistic timeline expectations:

1. Walk us through your standard process for bringing a multi-location optometry portfolio to market.
2. What pre-market preparation work do you require, and how long does that phase typically take?
3. How do you manage buyer qualification and confidentiality for sensitive healthcare transactions?
4. What is your typical time-to-close for transactions in our size range?

Valuation and Positioning Questions

Evaluate the broker’s analytical capabilities and market knowledge:

1. Based on preliminary information, what valuation range do you anticipate for our portfolio?
2. What specific factors would drive our valuation toward the upper end of that range?
3. How would you position our operational infrastructure to command premium multiples?
4. Describe comparable transactions you’ve completed that inform your valuation expectations.

Fee Structure and Terms

Confirm compensation details before entering final negotiations:

1. Provide a full fee schedule including base commission, retainer requirements, and any additional charges.
2. Under what circumstances would fees differ from your standard structure?
3. What performance incentives, if any, do you offer for exceeding initial valuation targets?
4. Describe your policy regarding fee adjustments if the transaction does not close.

How Do You Align Broker Selection with Portfolio Strategy?

Your broker selection should reflect your broader portfolio strategy. Different strategic objectives require different broker capabilities.

Growth Through Acquisition Strategy

If your group is primarily a buyer seeking to acquire additional practices, your broker relationship should emphasize buy-side capabilities. Key considerations include:

Groups executing roll-up strategies should consider retainer-based arrangements that incentivize proactive deal sourcing rather than reactive marketplace searches.

Portfolio Optimization Strategy

If your objective involves divesting underperforming locations while retaining core operations, you need a broker capable of presenting partial portfolio sales without undermining remaining operations. This requires careful buyer qualification to exclude competitors who might use the transaction to damage your retained locations.

The broker should also understand how to structure transactions that preserve operational continuity for retained practices, including shared services agreements, brand licensing, and transitional support arrangements.

Full Exit Strategy

PE-backed groups approaching investment timeline horizons need brokers experienced with platform sales to strategic or financial buyers. These transactions involve additional complexity including management incentive structures, earnout negotiations, and representations and warranties insurance considerations.

Full exit transactions also require sophisticated tax planning coordination. Your broker should work effectively with your tax advisors to structure transactions that optimize after-tax proceeds, which may involve installment sale structures, qualified small business stock elections, or opportunity zone reinvestment strategies.

The Integration Dimension: Why Post-Close Matters

Many groups overlook integration capabilities when selecting brokers, focusing exclusively on transaction execution. Deals that close well but integrate poorly destroy value rapidly. Your broker selection should account for post-close support requirements.

Transition Planning Support

Enterprise brokers should provide transition planning documentation that buyers can execute immediately after closing. This documentation includes staff communication templates, patient notification sequences, vendor transition checklists, and system migration timelines.

Groups that provide detailed transition planning receive higher valuations because buyers perceive lower integration risk. The quality of this preparation directly impacts buyer confidence and willingness to pay premium multiples.

Earnout Structure Expertise

Multi-location transactions frequently include earnout provisions tied to post-close performance. Your broker should understand how to negotiate earnout terms that are achievable based on historical performance while protecting against buyer manipulation of results.

Common earnout pitfalls include revenue recognition changes post-close, overhead allocation shifts, and marketing support reductions. Experienced brokers anticipate these issues and negotiate protective provisions.

Staff Retention Coordination

Key staff departures post-close represent one of the largest value destruction risks in healthcare M&A. Your broker should help you develop retention packages that buyers will honor and transition communication plans that minimize uncertainty-driven turnover.

The 90-day integration playbook approach provides a structured framework for managing these transitions effectively.

Building Your Broker Selection Scorecard

Create a quantitative evaluation framework to compare finalist brokers objectively. The following scorecard template provides a starting point for enterprise groups.

Establishing Evaluation Categories

Weight each category based on your specific priorities and transaction type. The suggested weights below reflect typical enterprise transaction priorities:

Scoring and Decision Making

Score each finalist on each dimension, weight the results, and use the total scores to inform your final selection. This quantitative approach reduces selection bias and creates documentation supporting your decision.

Common Selection Mistakes to Avoid

Enterprise groups frequently make avoidable errors when selecting brokers. Understanding these patterns helps you approach the process more effectively.

Prioritizing Fee Over Value

Selecting the lowest-cost broker often proves expensive. A broker charging 7% who achieves a 3.2x EBITDA multiple produces worse net proceeds than a broker charging 10% who achieves a 4.0x multiple. For a practice generating $1M EBITDA, the 7% broker delivers $2.976M after fees while the 10% broker delivers $3.6M after fees, a $624,000 difference favoring the more expensive option.

Focus your evaluation on demonstrated value creation, not fee minimization.

Ignoring Cultural Fit

Your broker will represent your organization to potential buyers for 6-12 months. Their professionalism, communication style, and market positioning reflect on your group. Select a broker whose approach aligns with how you want your organization perceived.

Cultural misalignment creates friction throughout the transaction process and may result in buyer perceptions that undermine valuation.

Underweighting Healthcare Expertise

General business brokers may offer lower fees and promise effective execution, but healthcare M&A requires specialized knowledge. Regulatory complexity, managed care contracting, and professional services dynamics create transaction risks that generalists frequently mismanage.

The healthcare operations M&A integration challenges demonstrate why specialized expertise matters throughout the transaction lifecycle.

Rushing the Selection Process

Broker selection should receive the same diligence you apply to other significant business decisions. Rushing the process based on timeline pressure or buyer urgency typically results in suboptimal representation.

Plan for 4-6 weeks to complete a thorough broker selection process including RFP distribution, proposal review, finalist interviews, and reference checks. This investment in upfront selection pays dividends throughout the transaction.

Key Takeaways

Selecting the right optometry practice broker for multi-location transactions requires enterprise-grade evaluation processes that go beyond reviewing credentials and comparing fees.

Enterprise broker selection priorities:

• Demonstrated multi-location optometry transaction experience with documented outcomes
• Active PE and strategic buyer relationships specific to your target transaction size
• Healthcare regulatory expertise including CPOM, Stark Law, and managed care considerations
• Technology platforms capable of managing complex portfolio transactions
• Integration support capabilities that reduce buyer risk perception
• Fee structures aligned with value creation rather than transaction processing

Process recommendations:

• Structure selection as a formal RFP process with consistent evaluation criteria
• Use quantitative scorecards to reduce selection bias
• Verify claimed expertise through reference checks and scenario-based questioning
• Allocate 4-6 weeks for thorough broker evaluation before engagement

The difference between adequate and excellent broker selection compounds across portfolio scale. For groups managing 5+ locations, investing appropriate time and rigor in broker selection produces materially better transaction outcomes.

Related Reading

• Guide for Selling Your Optometry Practice
• Optometry Practice Appraisal Process
• Optometry Practice Valuation Multiples 2026
• Pre-Sale Operational Cleanup for Intake and Valuation
• PE-Backed Healthcare Operations

Sources

1. Peak Business Valuation - Optometry Clinic Valuation Multiples
2. Kaufman Hall - Hospital and Health System M&A Trends 2024
3. Practice Transitions Group - How Do Brokers Get Paid
4. ODs on Finance - Methods of Valuing an Optometry Private Practice
5. SBA - Manage Your Business
6. Leerink Partners - Healthcare M&A Q2 2024 Trends
7. Morgan & Westfield - Business Broker and M&A Advisor Fees: A Comprehensive Guide

---